NKX2-2
Basic information
Region (hg38): 20:21511017-21514064
Previous symbols: [ "NKX2B" ]
Links
Phenotypes
GenCC
Source: 
- neonatal diabetes mellitus (Strong), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to 
- not_provided (32 variants)
- NKX2-2-related_disorder (5 variants)
- Inborn_genetic_diseases (5 variants)
- not_specified (4 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NKX2-2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000002509.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 19 | 21 | ||||
| missense | 10 | 15 | ||||
| nonsense | 1 | |||||
| start loss | 0 | |||||
| frameshift | 1 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 1 | 12 | 22 | 3 | 
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| NKX2-2 | protein_coding | protein_coding | ENST00000377142 | 2 | 3017 | 
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p | 
|---|---|---|---|---|---|---|
| 0.414 | 0.579 | 125711 | 0 | 4 | 125715 | 0.0000159 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.00371 | 161 | 161 | 0.999 | 0.00000724 | 1734 | 
| Missense in Polyphen | 29 | 53.303 | 0.54406 | 556 | ||
| Synonymous | -2.38 | 100 | 73.9 | 1.35 | 0.00000349 | 568 | 
| Loss of Function | 2.25 | 2 | 9.47 | 0.211 | 4.11e-7 | 101 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.00 | 0.00 | 
| Ashkenazi Jewish | 0.00 | 0.00 | 
| East Asian | 0.0000550 | 0.0000544 | 
| Finnish | 0.00 | 0.00 | 
| European (Non-Finnish) | 0.0000274 | 0.0000264 | 
| Middle Eastern | 0.0000550 | 0.0000544 | 
| South Asian | 0.00 | 0.00 | 
| Other | 0.00 | 0.00 | 
dbNSFP
Source: 
- Function
- FUNCTION: Transcriptional activator involved in the development of insulin-producting beta cells in the endocrine pancreas (By similarity). May also be involved in specifying diencephalic neuromeric boundaries, and in controlling the expression of genes that play a role in axonal guidance. Binds to elements within the NEUROD1 promoter (By similarity). {ECO:0000250|UniProtKB:P42586}.;
- Pathway
- Maturity onset diabetes of the young - Homo sapiens (human);Dopaminergic Neurogenesis;Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways (Consensus) 
Recessive Scores
- pRec
- 0.250
Intolerance Scores
- loftool
- 0.199
- rvis_EVS
- 0.51
- rvis_percentile_EVS
- 80.01
Haploinsufficiency Scores
- pHI
- 0.481
- hipred
- Y
- hipred_score
- 0.736
- ghis
- 0.412
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.942
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium | 
| Primary Immunodeficiency | Medium | Medium | Medium | 
| Cancer | Medium | Medium | Medium | 
Mouse Genome Informatics
- Gene name
- Nkx2-2
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; reproductive system phenotype; embryo phenotype;
Zebrafish Information Network
- Gene name
- nkx2.2a
- Affected structure
- myelinating Schwann cell
- Phenotype tag
- abnormal
- Phenotype quality
- mislocalised
Gene ontology
- Biological process
- type B pancreatic cell development;pancreatic A cell fate commitment;type B pancreatic cell fate commitment;pancreatic PP cell fate commitment;smoothened signaling pathway;brain development;response to glucose;oligodendrocyte development;spinal cord motor neuron differentiation;spinal cord oligodendrocyte cell fate specification;optic nerve development;cell differentiation;endocrine pancreas development;response to progesterone;negative regulation of neuron differentiation;positive regulation of neuron differentiation;positive regulation of transcription by RNA polymerase II;digestive tract development;neuron fate specification;astrocyte differentiation;positive regulation of oligodendrocyte differentiation;positive regulation of DNA-binding transcription factor activity;ventral spinal cord interneuron fate determination
- Cellular component
- nucleus;nucleoplasm
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;proximal promoter sequence-specific DNA binding;chromatin binding;DNA-binding transcription factor activity;transcription coactivator activity;transcription factor binding;sequence-specific DNA binding